Found 23 matching trials
Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma
PHASE1The purpose of this clinical trial is to learn if allogeneic cord blood-der...
Location
Xi'an No.3 Hospital
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
EARLY_PHASE1This is an exploratory, open-label, single-arm Phase 1 clinical study desig...
Location
Children's Hospital, Zhejiang University School of Medicine
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
PHASE1This is an investigator-initiated trial to evaluate the safety and efficacy...
Location
Changzhou No.2 People's Hospital
RN1201 Injection in the Treatment of Antibody-Mediated Diseases
PHASE1This single-arm, open-label exploratory trial aims to evaluate the safety, ...
Location
The First Affiliated Hospital of Soochow University
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
EARLY_PHASE1This is an exploratory, open-label, single-arm clinical study designed to e...
Location
Children's Hospital, Zhejiang University School of Medicine
UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases
EARLY_PHASE1This is an investigator-initiated trial to evaluate the safety and efficacy...
Location
The Affiliated Hospital of Xuzhou Medical University
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
PHASE1CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refract...
Location
Institute of Hematology & Blood Diseases Hospital
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis
EARLY_PHASE1This is an open label, single-site, dose-escalation study in up to 18 parti...
Location
The first affiliated hospital of medical college of zhejiang university
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Autoimmune Hemolytic Anemia
EARLY_PHASE1This is an open label, single-site, dose-escalation study in up to 18 parti...
Location
Multiple Locations
Allogeneic UCB-derived CAR-T for SLE
EARLY_PHASE1The purpose of this clinical trial is to learn if allogeneic, umbilical cor...
Location
Yancheng Third People's Hospital